Effect of the Consumption of Milk with Beta-Casein A2A2, Milk with Beta-Casein A1A2 and a Plant-Based Drink on Metabolic Health in Adults: Protocol IMPA-CT Study
Jadwiga Hamulka, Magdalena Górnicka, Anna Berthold-Pluta, Adam Kalinowski, Marta Habanova, Dawid Madej, Yingnan Jia · 2025
Read Effect of the Consumption of Milk with Beta-Casein A2A2, Milk with Beta-Casein A1A2 and a Plant-Based Drink on Metabolic Health in Adults: Protocol IMPA-CT Study by Jadwiga Hamulka, Magdalena Górnicka, Anna Berthold-Pluta, Adam Kalinowski, Marta Habanova, Dawid Madej, Yingnan Jia (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12735507.txt.
Description
Jadwiga Hamulka and co-authors published this study protocol in 2025. It sets out a randomized trial comparing three drinks: A2 milk, conventional milk, and an oat drink. The milks differ in one amino acid of their beta-casein protein, a change some claim makes A2 milk gentler and healthier; solid evidence is thin.
One hundred sixty-two adults aged thirty to sixty will drink half a liter of their assigned product daily for twelve weeks. Bone density is the main outcome, scanned at the start and end, with blood tests, body composition, and diet records at four checkpoints. Heart, metabolic, and immune markers form the secondary set. The trial is designed to separate true effects of the casein variant from the simple difference between milk and a plant drink. Results will inform a debate currently driven more by marketing than by trials, the authors suggest.
Catalog record
| CREATOR | Jadwiga Hamulka, Magdalena Górnicka, Anna Berthold-Pluta, Adam Kalinowski, Marta Habanova, Dawid Madej, Yingnan Jia |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |